BACKGROUND AND OBJECTIVES: Secondary analysis of the Hemodialysis Study showed that serum beta(2)-microglobulin levels predicted all-cause mortality and that high-flux dialysis was associated with decreased cardiac deaths in hemodialysis patients. This study examined the association of serum beta(2)-microglobulin levels and dialyzer beta(2)-microglobulin kinetics with the two most common causes of deaths: Cardiac and infectious diseases. Cox regression analyses were performed to relate cardiac or infectious deaths to cumulative mean follow-up predialysis serum beta(2)-microglobulin levels while controlling for baseline demographics, comorbidity, residual kidney function, and dialysis-related variables. RESULTS: The cohort of 1813 patients experienced 180 infectious deaths and 315 cardiac deaths. The adjusted hazard ratio for infectious death was 1.21 (95% confidence interval 1.07 to 1.37) per 10-mg/L increase in beta(2)-microglobulin. This association was independent of the prestudy years on dialysis. In contrast, the association between serum beta(2)-microglobulin level and cardiac death was not statistically significant. In similar regression models, higher cumulative mean Kt/V of beta(2)-microglobulin was not significantly associated with either infectious or cardiac mortality in the full cohort but exhibited trends suggesting an association with lower infectious mortality (relative risk 0.93; 95% confidence interval 0.86 to 1.01, for each 0.1-U increase in beta(2)-microglobulin Kt/V) and lower cardiac mortality (relative risk 0.93; 95% confidence interval 0.87 to 1.00) in the subgroup with >3.7 prestudy years of dialysis. CONCLUSIONS: These results generally support the notion that middle molecules are associated with systemic toxicity and that their accumulation predisposes dialysis patients to infectious deaths, independent of the duration of maintenance dialysis.
RCT Entities:
BACKGROUND AND OBJECTIVES: Secondary analysis of the Hemodialysis Study showed that serum beta(2)-microglobulin levels predicted all-cause mortality and that high-flux dialysis was associated with decreased cardiac deaths in hemodialysis patients. This study examined the association of serum beta(2)-microglobulin levels and dialyzer beta(2)-microglobulin kinetics with the two most common causes of deaths: Cardiac and infectious diseases. Cox regression analyses were performed to relate cardiac or infectious deaths to cumulative mean follow-up predialysis serum beta(2)-microglobulin levels while controlling for baseline demographics, comorbidity, residual kidney function, and dialysis-related variables. RESULTS: The cohort of 1813 patients experienced 180 infectious deaths and 315 cardiac deaths. The adjusted hazard ratio for infectious death was 1.21 (95% confidence interval 1.07 to 1.37) per 10-mg/L increase in beta(2)-microglobulin. This association was independent of the prestudy years on dialysis. In contrast, the association between serum beta(2)-microglobulin level and cardiac death was not statistically significant. In similar regression models, higher cumulative mean Kt/V of beta(2)-microglobulin was not significantly associated with either infectious or cardiac mortality in the full cohort but exhibited trends suggesting an association with lower infectious mortality (relative risk 0.93; 95% confidence interval 0.86 to 1.01, for each 0.1-U increase in beta(2)-microglobulin Kt/V) and lower cardiac mortality (relative risk 0.93; 95% confidence interval 0.87 to 1.00) in the subgroup with >3.7 prestudy years of dialysis. CONCLUSIONS: These results generally support the notion that middle molecules are associated with systemic toxicity and that their accumulation predisposes dialysis patients to infectious deaths, independent of the duration of maintenance dialysis.
Authors: M F Weiss; P Erhard; F A Kader-Attia; Y C Wu; P B Deoreo; A Araki; M A Glomb; V M Monnier Journal: Kidney Int Date: 2000-06 Impact factor: 10.612
Authors: Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek Journal: Kidney Int Date: 2003-05 Impact factor: 10.612
Authors: Michael Allon; Thomas A Depner; Milena Radeva; James Bailey; Srinivasan Beddhu; David Butterly; Daniel W Coyne; Jennifer J Gassman; Allen M Kaufman; George A Kaysen; Julia A Lewis; Steve J Schwab Journal: J Am Soc Nephrol Date: 2003-07 Impact factor: 10.121
Authors: Alfred K Cheung; Michael V Rocco; Guofen Yan; John K Leypoldt; Nathan W Levin; Tom Greene; Lawrence Agodoa; James Bailey; Gerald J Beck; William Clark; Andrew S Levey; Daniel B Ornt; Gerald Schulman; Steven Schwab; Brendan Teehan; Garabed Eknoyan Journal: J Am Soc Nephrol Date: 2005-12-28 Impact factor: 10.121
Authors: Alfred K Cheung; Mark J Sarnak; Guofen Yan; Michael Berkoben; Robert Heyka; Allen Kaufman; Julia Lewis; Michael Rocco; Robert Toto; David Windus; Daniel Ornt; Andrew S Levey Journal: Kidney Int Date: 2004-06 Impact factor: 10.612
Authors: Alfred K Cheung; Nathan W Levin; Tom Greene; Lawrence Agodoa; James Bailey; Gerald Beck; William Clark; Andrew S Levey; John K Leypoldt; Daniel B Ornt; Michael V Rocco; Gerald Schulman; Steve Schwab; Brendan Teehan; Garabed Eknoyan Journal: J Am Soc Nephrol Date: 2003-12 Impact factor: 10.121
Authors: Z Makita; S Radoff; E J Rayfield; Z Yang; E Skolnik; V Delaney; E A Friedman; A Cerami; H Vlassara Journal: N Engl J Med Date: 1991-09-19 Impact factor: 91.245
Authors: Gulay Asci; Huseyin Tz; Mehmet Ozkahya; Soner Duman; Meltem Sezis Demirci; Mustafa Cirit; Savas Sipahi; Hamad Dheir; Devrim Bozkurt; Fatih Kircelli; Ebru Sevinc Ok; Sinan Erten; Muhittin Ertilav; Timur Kose; Ali Basci; Jochen G Raimann; Nathan W Levin; Ercan Ok Journal: J Am Soc Nephrol Date: 2013-04-25 Impact factor: 10.121
Authors: M C Foster; D E Weiner; A G Bostom; M A Carpenter; L A Inker; P Jarolim; A A Joseph; J W Kusek; T Pesavento; M A Pfeffer; M Rao; S D Solomon; A S Levey Journal: Am J Transplant Date: 2017-03-30 Impact factor: 8.086
Authors: E Lars Penne; Neelke C van der Weerd; Peter J Blankestijn; Marinus A van den Dorpel; Muriel P C Grooteman; Menso J Nubé; Piet M Ter Wee; Renée Lévesque; Michiel L Bots Journal: Clin J Am Soc Nephrol Date: 2009-11-12 Impact factor: 8.237
Authors: Claire H den Hoedt; Michiel L Bots; Muriel P C Grooteman; Albert H A Mazairac; E Lars Penne; Neelke C van der Weerd; Piet M Ter Wee; Menso J Nubé; Renée Levesque; Peter J Blankestijn; Marinus A van den Dorpel Journal: PLoS One Date: 2013-04-19 Impact factor: 3.240